Tirzepatide
$119.98
Overview
Research-use dual GLP-1/GIP receptor agonist supplied for studies of incretin signaling, glucose-regulation pathways, and energy-balance models.
- Concentration
- 10 mg
- Stock
- In stock
Material profile
Tirzepatide is a synthetic dual GLP-1/GIP receptor agonist used in research models of incretin signaling and metabolic pathway biology. Pattern lists this material for controlled laboratory research.
- Research Targets
- GLP-1 receptor signaling, GIP receptor signaling, pancreatic and metabolic pathway models.
- Key Feature
- Dual incretin receptor agonist research peptide with fatty diacid design element.
- Research Focus Areas
- Incretin synergy, glucose-regulation pathway models, energy-balance signaling, pancreatic function studies.
- Common Models
- Rodent metabolic models, pancreatic function assays, receptor-signaling systems.
- Mechanistic Interests
- Dual receptor engagement, insulin secretion markers, cAMP pathway dynamics, metabolic hormone crosstalk.
- Use Boundary
- Research use only; not for human or veterinary use; no diagnostic, therapeutic, or consumption use is implied.
